On March 14, 2025, Seledora® Coronary Scoring Balloon Catheter, developed by Mixin Medtech(Suzhou) Co., Ltd., a subsidiary of Kossel Medtech (Suzhou) Co., Ltd., received approval from the National Medical Products Administration (NMPA) for market launch (Registration No. 20253030586). Kossel's indep
On March 14, 2025, the Octoparms® II vena cava filter independently developed by Kossel Medtech (Suzhou) Co., Ltd. was approved by the National Drug Administration (NMPA). (registration number is 20253130576). In addition, the Seledora® coronary scoring balloon catheter developed by the subsidiary M
The MiStent coronary drug-eluting stent, an important overseas transformation project of Corecell Medical, has officially entered the Chinese market with two major advantages of "rapid healing and long-lasting efficacy", providing a new clinical option for PCI surgeries.This issue will introduce the